Stem Cell Research ( IF 0.8 ) Pub Date : 2020-08-19 , DOI: 10.1016/j.scr.2020.101957 Sandra Ratnavadivel 1 , Marcelo Szymanski de Toledo 2 , Torsten Bloch Rasmussen 3 , Tomo Šarić 4 , Jan Gummert 1 , Martin Zenke 2 , Hendrik Milting 1
Arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC-5) is a dominantly inherited cardiomyopathy caused by the mutation TMEM43-p.S358L. An induced pluripotent stem cell (iPSC) line (HDZi001-A) from an adult male mutation carrier was generated, using the CytoTune Sendai Kit. The resulting iPSCs carried the mutation TMEM43-p.S358L, had a normal morphology, a stable karyotype and were positive for the expression of pluripotency markers. This iPSC line can be differentiated into the three germ layers and might be a useful model for the characterization of ARVC-5 associated pathomechanism.
中文翻译:
人多能干细胞系(HDZi001-A)来自携带ARVC-5相关突变TMEM43-p.S358L的患者。
5型心律失常性右室心肌病(ARVC-5)是由TMEM43- p.S358L突变引起的显性遗传性心肌病。使用CytoTune Sendai试剂盒,从成年男性突变载体产生了诱导性多能干细胞(iPSC)系(HDZi001-A)。产生的iPSC携带突变TMEM43- p.S358L,具有正常形态,稳定的核型,并且多能性标记物的表达是阳性的。该iPSC品系可以分为三个胚层,并且可能是表征ARVC-5相关致病机理的有用模型。